Influence of stabilizer systems on the properties and phase behavior of supercooled smectic nanoparticles

Journal of Colloid and Interface Science

Volumn 350, Issue 1, 2010, Pages 229-239

  Kuntsche, Judith ^a   Koch, Michel H J ^b   Steiniger, Frank ^a   Bunjes, Heike ^a,c  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Crystallization; Lipid nanoparticles; Smectic phase; Stabilizer; Supercooling

Indexed keywords

ACYL GROUP; CARRIER SYSTEMS; CHOLESTEROL ESTERS; CHOLESTERYL MYRISTATE; COLLOIDAL DISPERSION; CRYSTALLIZATION BEHAVIOR; DIFFERENTIAL SCATTERING; FATTY ACID CHAINS; HIGH STABILITY; LASER DIFFRACTIONS; LIPID NANOPARTICLES; MONOLAURATE; NEGATIVE STAINING; POLAR HEADGROUPS; POLARIZATION INTENSITIES; POLOXAMER; POLOXAMINES; POLYSORBATE 80; POORLY WATER-SOLUBLE DRUGS; RECRYSTALLIZATIONS; SMALL ANGLE X-RAY SCATTERING; SMECTIC PHASE; SODIUM OLEATE; STABILIZER; TEM;

CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DYNAMIC LIGHT SCATTERING; EMULSIFICATION; ESTERS; FATTY ACIDS; LIGHT TRANSMISSION; METALLIC GLASS; ORGANIC POLYMERS; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; RECRYSTALLIZATION (METALLURGY); SCANNING ELECTRON MICROSCOPY; SCATTERING; SODIUM; SUGAR (SUCROSE); SUPERCOOLING; SYSTEM STABILITY; TRANSMISSION ELECTRON MICROSCOPY; X RAY SCATTERING;

NANOPARTICLES;

CHOLESTERYLMYRISTATE; EMULSIFYING AGENT; FATTY ACID; FATTY ACYL GROUP; GELATIN; GELATIN POLYSUCCINATE; GLYCOCHOLATE SODIUM; MYRISTIC ACID DERIVATIVE; NANOPARTICLE; OLEATE SODIUM; PHOSPHOLIPID; POLOXAMER; POLOXAMINE 908; POLYSORBATE 80; POLYVINYL ALCOHOL; SUCROSE LAURATE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; COLLOID; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; ELECTRON MICROSCOPY; ENTHALPY; LASER DIFFRACTION; LIGHT SCATTERING; PARTICLE SIZE; POLARIZATION; PRIORITY JOURNAL; RADIATION SCATTERING; STORAGE; STRUCTURE ANALYSIS; SYNCHROTRON; TRANSMISSION ELECTRON MICROSCOPY;

CALORIMETRY, DIFFERENTIAL SCANNING; DRUG STABILITY; DRUG STORAGE; EMULSIFYING AGENTS; LIQUID CRYSTALS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; NANOPARTICLES; PARTICLE SIZE; PHASE TRANSITION;

EID: 77955334511     PISSN: 00219797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcis.2010.06.018     Document Type: Article

References (36)

1. Kuntsche J., Westesen K., Drechsler M., Koch M.H.J., Bunjes H. Pharm. Res. 2004, 21:1834.
2. Kuntsche J., Koch M.H.J., Drechsler M., Bunjes H. Colloids Surf. B 2005, 44:25.
3. Kuntsche J., Bunjes H. Eur. J. Pharm. Biopharm. 2007, 67:612.
4. Kuntsche J., Koch M.H.J., Fahr A., Bunjes H. Eur. J. Pharm. Sci. 2009, 38:238.
5. Hevonoja T., Pentikäinen M.O., Hyvönen M.T., Kovanen P.T., Ala-Korpela M. Biochim. Biophys. Acta 2000, 1488:189.
6. Ginsburg G.S., Atkinson D., Small D.M. Prog. Lipid Res. 1984, 23:135.
7. Mehnert W., Mäder K. Adv. Drug Delivery Rev. 2001, 47:165.
8. Bunjes H., Siekmann B., Westesen K. Submicron Emulsions in Drug Targeting and Delivery 1998, 175. Harwood Academic Press, Amsterdam. S. Benita (Ed.).
9. Blümer C., Mäder K. Pharm. Res. 2005, 22:1708.
10. Hamada Y., Kobayashi I., Nakajima M., Sato K. Cryst. Growth Des. 2002, 2:579.
11. Ueno S., Hamada Y., Sato K. Cryst. Growth Des. 2003, 3:935.
12. Bunjes H., Koch M.H.J., Westesen K. J. Pharm. Sci. 2003, 92:1509.
13. Rosenblatt K.M., Bunjes H. H. Mol. Pharmaceutics 2009, 6:105.
14. Bunjes H., Koch M.H.J. J. Controlled Release 2005, 107:229.
15. Bunjes H., Steiniger F., Richter W. Langmuir 2007, 23:4005.
16. Unruh T., Bunjes H., Westesen K., Koch M.H.J. J. Phys. Chem. B 1999, 103:10373.
17. Hecht E., Hoffmann H. Colloids Surf. A 1995, 96:181.
18. Gainsford S., Beezer A.E., Mitchell J.C., Bell P.C., Fakorede F., Finnie J.K., Williams S.J. Int. J. Pharm. 1998, 174:39.
19. Scherlund M., Brodin A., Malmsten M. Int. J. Pharm. 2000, 211:37.
20. Illing A., Unruh T., Koch M.H.J. Pharm. Res. 2004, 21:592.
21. Rotenberg M., Rubin M., Bor A., Meyuhas D., Talmon Y., Lichtenberg D. Biochim. Biophys. Acta 1991, 1086:265.
22. Westesen K., Wehler T. J. Pharm. Sci. 1992, 81:777.
23. Venkatesh S., Li J., Caldwell K.D., Anderson B.D. J. Pharm. Sci. 1998, 87:859.
24. Westesen K., Siekmann B. Int. J. Pharm. 1997, 151:35.
25. Sjöström B., Kaplun A., Talmon Y., Cabane B. Pharm. Res. 1995, 12:39.
26. Hajri T., Férézou J., Lutton C. Biochim. Biophys. Acta 1990, 1047:121.
27. Bach A.C., Férézou J., Frey A. Prog. Lipid Res. 1996, 35:133.
28. Small D.M., Penkett S.A., Chapman D. Biochim. Biophys. Acta 1969, 176:178.
29. Schurtenberger P., Mazer N., Känzig W. J. Phys. Chem. 1985, 89:1042.
30. Almgren M. Biochim. Biophys. Acta 2000, 1508:146.
31. Edwards K., Silvander M., Karlsson G. Langmuir 1995, 11:2429.
32. van Antwerpen R., Gilkey J.C. J. Lipid Res. 1994, 35:2223.
33. Orlowa E.V., Sherman M.B., Chiu W., Mowri H., Smith L.C., Gotto A.M. Proc. Natl. Acad. Sci. USA 1999, 96:8420.
34. Kroon P.A. J. Biol. Chem. 1981, 256:5339.
35. Gabizon A., Shmeeda H., Barenholz Y. Clin. Pharmacokinet. 2003, 42:419.
36. Reddy P.R., Venkateswarlu V. J. Drug Targeting 2005, 13:543.